230 related articles for article (PubMed ID: 25568316)
21. Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.
Beers SA; Chan CH; James S; French RR; Attfield KE; Brennan CM; Ahuja A; Shlomchik MJ; Cragg MS; Glennie MJ
Blood; 2008 Nov; 112(10):4170-7. PubMed ID: 18583569
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
[TBL] [Abstract][Full Text] [Related]
23. Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody.
White AL; Chan HT; Roghanian A; French RR; Mockridge CI; Tutt AL; Dixon SV; Ajona D; Verbeek JS; Al-Shamkhani A; Cragg MS; Beers SA; Glennie MJ
J Immunol; 2011 Aug; 187(4):1754-63. PubMed ID: 21742972
[TBL] [Abstract][Full Text] [Related]
24. [Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].
Zhu Y; Zhuang Y; Yang GH; Qiang XF; Yang L; Shen YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):135-9. PubMed ID: 23484707
[TBL] [Abstract][Full Text] [Related]
25. Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL).
Elias S; Kahlon S; Kotzur R; Kaynan N; Mandelboim O
Oncoimmunology; 2018; 7(6):e1428158. PubMed ID: 29872553
[TBL] [Abstract][Full Text] [Related]
26. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
[TBL] [Abstract][Full Text] [Related]
27. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface.
Al-Zoobi L; Salti S; Colavecchio A; Jundi M; Nadiri A; Hassan GS; El-Gabalawy H; Mourad W
Int Immunol; 2014 Aug; 26(8):451-65. PubMed ID: 24894009
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
[TBL] [Abstract][Full Text] [Related]
30. The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases.
Huang ZY; Hunter S; Kim MK; Chien P; Worth RG; Indik ZK; Schreiber AD
J Leukoc Biol; 2004 Aug; 76(2):491-9. PubMed ID: 15136586
[TBL] [Abstract][Full Text] [Related]
31. ImmunoPET of Malignant and Normal B Cells with
Zettlitz KA; Tavaré R; Knowles SM; Steward KK; Timmerman JM; Wu AM
Clin Cancer Res; 2017 Dec; 23(23):7242-7252. PubMed ID: 28928164
[No Abstract] [Full Text] [Related]
32. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with
Yoon JT; Longtine MS; Marquez-Nostra BV; Wahl RL
J Nucl Med; 2018 Aug; 59(8):1219-1224. PubMed ID: 29348316
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphism of the inhibitory IgG Fc receptor FcgammaRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab.
Weng WK; Levy R
Leuk Lymphoma; 2009 May; 50(5):723-7. PubMed ID: 19452316
[TBL] [Abstract][Full Text] [Related]
34. Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies.
Tipton TR; Roghanian A; Oldham RJ; Carter MJ; Cox KL; Mockridge CI; French RR; Dahal LN; Duriez PJ; Hargreaves PG; Cragg MS; Beers SA
Blood; 2015 Mar; 125(12):1901-9. PubMed ID: 25631769
[TBL] [Abstract][Full Text] [Related]
35. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
Robak T; Robak E
BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
[TBL] [Abstract][Full Text] [Related]
36. Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.
Capuano C; Romanelli M; Pighi C; Cimino G; Rago A; Molfetta R; Paolini R; Santoni A; Galandrini R
Cancer Res; 2015 Oct; 75(19):4097-108. PubMed ID: 26229120
[TBL] [Abstract][Full Text] [Related]
37. HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
Hussain K; Liu R; Smith RCG; Müller KTJ; Ghorbani M; Macari S; Cleary KLS; Oldham RJ; Foxall RB; James S; Booth SG; Murray T; Dahal LN; Hargreaves CE; Kemp RS; Longley J; Douglas J; Markham H; Chee SJ; Stopforth RJ; Roghanian A; Carter MJ; Ottensmeier CH; Frendéus B; Cutress RI; French RR; Glennie MJ; Strefford JC; Thirdborough SM; Beers SA; Cragg MS
J Exp Clin Cancer Res; 2022 Apr; 41(1):131. PubMed ID: 35392965
[TBL] [Abstract][Full Text] [Related]
38. Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex.
Stamou M; Grodzki AC; van Oostrum M; Wollscheid B; Lein PJ
J Neuroinflammation; 2018 Jan; 15(1):7. PubMed ID: 29306331
[TBL] [Abstract][Full Text] [Related]
39. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
40. Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.
Huang ZY; Barreda DR; Worth RG; Indik ZK; Kim MK; Chien P; Schreiber AD
J Leukoc Biol; 2006 Dec; 80(6):1553-62. PubMed ID: 16921024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
